• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗血小板药物在心脏病中的应用。

The use of antiplatelet agents in cardiac disease.

作者信息

Tepper D, Ip R J, Ip J H

机构信息

AV-MED HealthPlan, Fort Lauderdale, Florida, USA.

出版信息

Manag Care Interface. 2000 May;13(5):76-8.

PMID:11067401
Abstract

In this clinical review, the authors focus on the process of platelet activation and thrombosis in acute and chronic coronary syndromes. New antithrombotic therapies have emerged for various cardiovascular diseases, based on the evolving concept of vascular injury and platelets and the knowledge of the pathophysiology of the underlying disease states. An understanding of these mechanisms is crucial to therapeutic decision making with antiplatelet regimens, which are also discussed in detail.

摘要

在这篇临床综述中,作者聚焦于急性和慢性冠状动脉综合征中血小板激活与血栓形成的过程。基于不断发展的血管损伤和血小板概念以及对潜在疾病状态病理生理学的认识,针对各种心血管疾病出现了新的抗栓治疗方法。理解这些机制对于抗血小板治疗方案的决策至关重要,本文也将对此进行详细讨论。

相似文献

1
The use of antiplatelet agents in cardiac disease.抗血小板药物在心脏病中的应用。
Manag Care Interface. 2000 May;13(5):76-8.
2
Platelet inhibitor therapy for patients with cardiovascular disease: looking toward the future.
Curr Hematol Rep. 2005 Sep;4(5):397-404.
3
The antiplatelet effects of nitrates: is it of clinical significance in patients with cardiovascular disease?硝酸盐的抗血小板作用:在心血管疾病患者中是否具有临床意义?
Cardiol Rev. 2010 Jul-Aug;18(4):198-203. doi: 10.1097/CRD.0b013e3181d74582.
4
Antiplatelet agents: current drugs and future trends.抗血小板药物:当前药物与未来趋势。
Hematol Oncol Clin North Am. 2005 Feb;19(1):87-117, vi. doi: 10.1016/j.hoc.2004.09.004.
5
The P2Y12 receptor as a therapeutic target in cardiovascular disease.P2Y12受体作为心血管疾病的治疗靶点
Platelets. 2001 Jun;12(4):197-209. doi: 10.1080/09537100120058739.
6
Platelet biology and response to antiplatelet therapy in women: implications for the development and use of antiplatelet pharmacotherapies for cardiovascular disease.血小板生物学和抗血小板治疗反应在女性中的作用:对开发和使用抗血小板药物治疗心血管疾病的影响。
J Am Coll Cardiol. 2012 Mar 6;59(10):891-900. doi: 10.1016/j.jacc.2011.09.075.
7
Current concepts in antiplatelet therapy for cardiovascular disease.心血管疾病抗血小板治疗的当前概念
JAAPA. 2004 Mar;17(3):16-20, 23-4; quiz 51-2.
8
Controversies surrounding platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention and acute coronary syndromes.经皮冠状动脉介入治疗和急性冠状动脉综合征中血小板糖蛋白IIb/IIIa抑制剂的相关争议。
Semin Thromb Hemost. 2004 Dec;30(6):639-47. doi: 10.1055/s-2004-861506.
9
Antiplatelet drugs in cardiovascular diseases.心血管疾病中的抗血小板药物。
Int J Clin Pract. 2003 Dec;57(10):898-905.
10
Evidence-based prescribing and adherence to antiplatelet therapy--how much difference do they make to patients with atherothrombosis?循证用药与抗血小板治疗的依从性——它们对动脉粥样硬化血栓形成患者有多大影响?
Int J Cardiol. 2009 May 15;134(2):150-9. doi: 10.1016/j.ijcard.2009.02.006. Epub 2009 Mar 17.